News for Theratechnologies Inc. (THTX)

Achieved record positive Adjusted EBITDA* of $20 million for FY2024 (net loss of $8.3 million), exceeding latest guidance of $17-19 million Achieved record qua

**media[550847]**

Theratechnologies Inc (TSX:TH) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 2024 revenue is $32.32 million, and the ear

Overview of Morgan Stanley's Recent Transaction On December 31, 2024, Morgan Stanley executed a significant transaction by acquiring an additional 59,875 shares

**media[540760]**

Theratechnologies (THTX) said there will be a shortage of its drug Egrifta SV on the patient level in mid-January due to a manufacturing shutdown last year. Read more here.

**media[511199]**

Theratechnologies Provides Update on EGRIFTA SV ® Supply

**media[496017]**

MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company foc…

**media[488808]**

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA

No dose-limiting toxicities reported in two different weekly doses in heavily pre-treated patients Preliminary evidence of dose response includes significant

Addition of investigational RNA-targeted medicines build upon Theratechnologies' foundational HIV portfolio Submissions to Health Canada planned for 2025 MONT

MONTREAL, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (”œTheratechnologies” or the ”œCompany”) (TSX: TH) ( THTX), a biopharmaceutical compa

**media[482657]**

Japan-based BloomZ Inc. (BLMZ) is up over 95 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

U.K.-based energy business VivoPower International PLC (VVPR) is up over 90 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical…